Found 0 matching trials
This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS). PHASE3 The purpose of this study was to demonstrate superiority of secukinumab at ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Secukinumab Open Label Roll-over Extension Protocol PHASE4 The purpose of this study is to assess long term safety in participants who...
Show More Location
Providence Medical Foundation
Learn More & Join Trial
A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis PHASE2 The purpose of the study is to determine whether, in patients with moderate...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
PsA Secukinumab XCT Structural Progression Study PHASE4 Psoriatic arthritis is related with chronic inflammation and progressive ra...
Show More Location
Department of Medicine and Therapeutics
Learn More & Join Trial
Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa PHASE3 The purpose of this extension study is to evaluate maintenance of Hidradeni...
Show More Location
Northwest Arkansas Center
Learn More & Join Trial
Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy PHASE3 The purpose of the present study was to assess the efficacy of secukinumab ...
Show More Location
Millennium Clinical Trials
Learn More & Join Trial
Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1) PHASE3 The core and extension studies assessed the safety and efficacy of secukinu...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients PHASE4 The purpose of this study is to evaluate the clinical efficacy, safety and ...
Show More Learn More & Join Trial
Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus PHASE2 This study will assess the safety and efficacy of secukinumab on the preser...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Managed Access Programs for AIN457, Secukinumab N/A The purpose of this registration is to list Managed Access Programs (MAPs) ...
Show More Location
Multiple Locations
Learn More & Join Trial